| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.091 | 0.09 |